LMAT Q4 2024 Earnings — LeMaitre Vascular, Inc. Revenue & Financial Results | Market Cap Arena

LMATLeMaitre Vascular, Inc.

$3B

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$56M+14.0% YoY

Gross Profit

$39M69.3% margin

Operating Income

$13M23.1% margin

Net Income

$11M20.1% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$552M

Total Liabilities

$215M

Stockholders' Equity

$337M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56M	$49M	+14.0%
Gross Profit	$39M	$33M	+16.0%
Operating Income	$13M	$10M	+25.9%
Net Income	$11M	$8M	+32.1%

Geographic Segments

Americas

$74M66%

EMEA

$31M27%

Asia Pacific

$7M7%